<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus associated <z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">lymphoproliferative disease</z:e> after autologous bone marrow transplantation (ABMT) has rarely been reported </plain></SENT>
<SENT sid="1" pm="."><plain>We report a case of B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> following ABMT for T-<z:hpo ids='HP_0011009'>acute</z:hpo> lymphoblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath>; bone marrow was purged in vitro with monoclonal antibodies to remove T cells </plain></SENT>
<SENT sid="2" pm="."><plain>Immunoglobulin and T-cell receptor gene rearrangement studies were used to demonstrate clonality and to show that this patient developed a second <z:hpo ids='HP_0002664'>neoplasm</z:hpo> after ABMT </plain></SENT>
<SENT sid="3" pm="."><plain>EBV proteins and genome (type A) were present in post-transplantation <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, suggesting a causative role in its development </plain></SENT>
</text></document>